Cargando…
The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
Contralateral risk-reducing mastectomy (CRRM) rates have tripled over the last 2 decades. Reasons for this are multi-factorial, with those harbouring a pathogenic variant in the BRCA1/2 gene having the greatest survival benefit. On May 14th, 2013, Angelina Jolie shared the news of her bilateral risk...
Autores principales: | Basu, Narendra Nath, Hodson, James, Chatterjee, Shaunak, Gandhi, Ashu, Wisely, Julie, Harvey, James, Highton, Lyndsey, Murphy, John, Barnes, Nicola, Johnson, Richard, Barr, Lester, Kirwan, Cliona C., Howell, Sacha, Baildam, Andrew D., Howell, Anthony, Evans, D. Gareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854742/ https://www.ncbi.nlm.nih.gov/pubmed/33531640 http://dx.doi.org/10.1038/s41598-021-82654-x |
Ejemplares similares
-
Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
por: Evans, D. Gareth, et al.
Publicado: (2015) -
Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect
por: Liede, Alexander, et al.
Publicado: (2018) -
The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015) -
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021) -
Celebrity disclosures and information seeking: The case of Angelina Jolie
por: Juthe, Robin H., et al.
Publicado: (2014)